124 related articles for article (PubMed ID: 9360397)
1. [Protective antigen of influenza virus].
Nobusawa E
Nihon Rinsho; 1997 Oct; 55(10):2719-24. PubMed ID: 9360397
[TBL] [Abstract][Full Text] [Related]
2. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition.
Johansson BE; Kilbourne ED
Virology; 1996 Nov; 225(1):136-44. PubMed ID: 8918540
[TBL] [Abstract][Full Text] [Related]
3. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
Li S; Liu C; Klimov A; Subbarao K; Perdue ML; Mo D; Ji Y; Woods L; Hietala S; Bryant M
J Infect Dis; 1999 May; 179(5):1132-8. PubMed ID: 10191214
[TBL] [Abstract][Full Text] [Related]
4. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.
Kilbourne ED; Cerini CP; Khan MW; Mitchell JW; Ogra PL
J Immunol; 1987 May; 138(9):3010-3. PubMed ID: 3571981
[TBL] [Abstract][Full Text] [Related]
5. Antigenic analysis of recent H1N1 influenza viruses with monoclonal antibodies.
Yamada A; Cao MS; Imanishi J; Oyama S; Abe A; Katagiri S
Acta Virol; 1991 Aug; 35(4):343-9. PubMed ID: 1724874
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
Jadhao SJ; Lee CW; Sylte M; Suarez DL
Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
[TBL] [Abstract][Full Text] [Related]
7. Specific antibody responses and generation of antigenic variants in chickens immunized against a virulent avian influenza virus.
Hinshaw VS; Sheerar MG; Larsen D
Avian Dis; 1990; 34(1):80-6. PubMed ID: 1690984
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies differentially affect the interaction between the hemagglutinin of H9 influenza virus escape mutants and sialic receptors.
Ilyushina N; Rudneva I; Gambaryan A; Bovin N; Kaverin N
Virology; 2004 Nov; 329(1):33-9. PubMed ID: 15476872
[TBL] [Abstract][Full Text] [Related]
9. Immunity to influenza.
Schild GC; Oxford JS; Virelizier JL
Dev Biol Stand; 1975; 28():253-72. PubMed ID: 47824
[TBL] [Abstract][Full Text] [Related]
10. [The nature of amino acid substitution in antigenic drift of hemagglutinin N3 and neuraminidase N2 from the influenza virus].
Eroshkin AM; Kulichkov VA
Mol Biol (Mosk); 1986; 20(2):546-57. PubMed ID: 2422540
[TBL] [Abstract][Full Text] [Related]
11. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
Brett IC; Johansson BE
Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
[TBL] [Abstract][Full Text] [Related]
12. [Antigenic structure of influenza A virus subtype H5 hemagglutinin: mechanism of acquiring stability to monoclonal antibodies in escape-mutants].
Il'iushina NA; Rudneva IA; Varich NL; Lipatov AS; Webster RG; Kaverin NV
Mol Gen Mikrobiol Virusol; 2003; (1):40-5. PubMed ID: 12656046
[TBL] [Abstract][Full Text] [Related]
13. Influenza vaccine immunology.
Dormitzer PR; Galli G; Castellino F; Golding H; Khurana S; Del Giudice G; Rappuoli R
Immunol Rev; 2011 Jan; 239(1):167-77. PubMed ID: 21198671
[TBL] [Abstract][Full Text] [Related]
14. Escape mutants of pandemic influenza A/H1N1 2009 virus: variations in antigenic specificity and receptor affinity of the hemagglutinin.
Rudneva I; Ignatieva A; Timofeeva T; Shilov A; Kushch A; Masalova O; Klimova R; Bovin N; Mochalova L; Kaverin N
Virus Res; 2012 Jun; 166(1-2):61-7. PubMed ID: 22459010
[TBL] [Abstract][Full Text] [Related]
15. Antigenic variation and the structure of influenza virus glycoproteins.
Laver WG
Microbiol Sci; 1984 May; 1(2):37-43. PubMed ID: 6444094
[TBL] [Abstract][Full Text] [Related]
16. A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model.
Horimoto T; Takada A; Iwatsuki-Horimoto K; Kawaoka Y
Vaccine; 2004 Jun; 22(17-18):2244-7. PubMed ID: 15149783
[TBL] [Abstract][Full Text] [Related]
17. Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A:H3N2 viruses isolated in Canada.
Abed Y; Hardy I; Li Y; Boivin G
J Med Virol; 2002 Aug; 67(4):589-95. PubMed ID: 12116009
[TBL] [Abstract][Full Text] [Related]
18. Differences between original strains and their mouse-adapted variants of human (H1) and avian (H2) influenza A viruses in the reaction with cross-neutralizing monoclonal antibody recognizing conformational epitope.
Lipatov AS; Gitelman AK; Smirnov YuA
Acta Virol; 1996 Sep; 40(4):227-30. PubMed ID: 9014015
[TBL] [Abstract][Full Text] [Related]
19. Antigenic variation of neuraminidase of human type A influenza (H3N2) viruses isolated in Berlin (West).
Werner J; Schudrowitz C; Köhler H
Zentralbl Bakteriol Orig A; 1975 Dec; 233(4):440-6. PubMed ID: 56831
[TBL] [Abstract][Full Text] [Related]
20. Stalking influenza diversity with a universal antibody.
Russell CJ
N Engl J Med; 2011 Oct; 365(16):1541-2. PubMed ID: 22010922
[No Abstract] [Full Text] [Related]
[Next] [New Search]
